Moreover, we found that the expression of CD163 is significantly high in high‐IGF2BP2 group in TCGA‐BLCA (Figure 7C), consistent with the immunofluorescence result. This evidence concerns the gene IGF2BP2 and bladder transitional cell carcinoma.